Trials / Completed
CompletedNCT00334906
Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)
An Open-Label Exploratory Study With Memantine: Assessment of Selected Measures of Volumetric MRI and Cognition in Patients With Moderate Dementia of the Alzheimer's Type
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 75 (planned)
- Sponsor
- Forest Laboratories · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to characterize the progression of disease using volumetric MRI techniques and cognitive outcome measures in patients with moderate dementia of the Alzheimer's type treated with open-label memantine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | memantine HCl |
Timeline
- Start date
- 2005-07-01
- Primary completion
- 2007-11-01
- First posted
- 2006-06-08
- Last updated
- 2008-01-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00334906. Inclusion in this directory is not an endorsement.